Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prophylactic half-dose platelet transfusion effect on thrombocytopenia, transfusion, and bleeding occurrence in patients with hematologic disease.

American journal of clinical pathology·2026

Same author

The case for washing red blood cells and platelets - A concise review of donors, processes, and products.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same author

The case against infusing ABO incompatible antibody and antigen from all blood components.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026

Same author

Whole Blood versus Components for Transfusion in Trauma and Life-Threatening Hemorrhage-Unresolved Issues.

Anesthesia and analgesia·2026

Same author

The case for universal leukoreduction of blood transfusions.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025

Same author

Differences in outcomes associated with ABO blood groups in recipients of IVIG.

Blood vessels, thrombosis & hemostasis·2025

Same journal

Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?

F1000 medicine reports·2013

Same journal

Advances in lens implant technology.

F1000 medicine reports·2013

Same journal

Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population.

F1000 medicine reports·2013

Same journal

Cannabis and psychosis: what causes what?

F1000 medicine reports·2013

Same journal

Prevention of atopic dermatitis.

F1000 medicine reports·2012

Same journal

Lung inflammation in COPD: why does it matter?

F1000 medicine reports·2012

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Platelet transfusions: trigger, dose, benefits, and risks.

Neil Blumberg, Joanna M Heal, Gordon L Phillips

F1000 Medicine Reports

|May 27, 2010

Summary

This summary is machine-generated.

Platelet transfusion practices are being re-evaluated. Lower thresholds and doses may be safe and effective, reducing risks and improving platelet availability for patients needing transfusions.

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Area of Science:

Hematology
Transfusion Medicine

Background:

Platelet transfusions are vital for preventing bleeding in hematologic malignancies.
Current transfusion practices may be suboptimal, with potential risks and resource limitations.

Purpose of the Study:

To review recent evidence challenging traditional platelet transfusion thresholds and strategies.
To inform optimal clinical decision-making regarding prophylactic and therapeutic platelet transfusions.

Main Methods:

Review of recent randomized trials and observational data on platelet transfusion practices.
Analysis of risks associated with current transfusion thresholds and doses.

Main Results:

Lower prophylactic platelet count thresholds (e.g., 10,000/µL) may be safe.
Therapeutic transfusion strategies and very low transfusion doses appear effective.
The 50,000/µL threshold for invasive procedures lacks strong evidence and may lead to unnecessary transfusions.

Conclusions:

Evidence suggests current platelet transfusion guidelines can be refined.
Lowering transfusion thresholds and doses may reduce risks and optimize resource use.
Further research is needed to establish evidence-based thresholds for specific procedures.